Silverback Therapeutics shares owned by Hanson McClain Advisors
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Hanson McClain Advisors
from 13F filings
Historical chart of Hanson McClain Advisors investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Silverback Therapeutics by Hanson McClain Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $838 | 82 | 10.23 |